Mr. Arun Nayyar reports

VANC PHARMACEUTICALS ANNOUNCES LOW COST ALTERNATIVE APPROVAL OF 14 PRODUCTS FROM BRITISH COLUMBIA MINISTRY OF HEALTH

Vanc Pharmaceuticals Inc. has received confirmation from the B.C. Ministry of Health approving 14 of the company's generic molecules under the Low Cost Alternative program. The approval of these molecules makes them eligible for listing on British Columbia's provincial formulary and for reimbursement through Pharmacare. Pharmacare is the province's coverage plan that assists residents with the cost of eligible prescription drugs and certain medical supplies.

"We are excited to have received LOA approval from the B.C. Ministry of Health as it signifies an important milestone in our evolution as a company -- we can now provide residents of B.C. with safety, quality and affordability when it comes to these 14 molecules," said Arun Nayyar, chief executive officer of Vanc. "We will continue to work with the Ministry of Health to gain approval of additional molecules during Q1 2015."

                         14 APPROVED PRODUCTS
                                                                Brand
Molecule name                               Presentations   reference

VAN-Rizatriptan                                  5 mg tab      Maxalt
VAN-Amlodipine                         5 mg and 10 mg tab     Norvasc
VAN-Losartan                  25 mg, 50 mg and 100 mg tab      Cozaar
VAN-Losartan-HCTZ            50+12.5 mg and 100+25 mg tab      Hyzaar
VAN-Levetiracetam           250 mg, 500 mg and 750 mg tab      Keppra
VAN-Gabapentin tab                  600 mg and 800 mg tab   Neurontin
VAN-Omeperazole                              20 mg DR tab       Losec
VAN-Finasteride                                  5 mg tab     Proscar
VAN-Olanzapine      2.5 mg, 5 mg, 7.5 mg, 10 mg and 15 mg     Zyprexa
                                                      tab
VAN-Sertraline cap            25 mg, 50 mg and 100 mg cap      Zoloft
VAN-Pantoprazole                                40 mg tab    Pantoloc
VAN-Gabapentin cap          100 mg, 300 mg and 400 mg cap   Neurontin
VAN-Ciprofloxacin           250 mg, 500 mg and 750 mg tab       Cipro
VAN-Sildenafil                25 mg, 50 mg and 100 mg tab      Viagra

About Low Cost Alternative program

The B.C. Ministry of Health established the Low Cost Alternative program under the Drug Price Regulation to ensure the best value is obtained for expenditures on multisource drugs. The program works by limiting Pharmacare reimbursements for drug products subject to an LCA price.

We seek Safe Harbor.